BERKELEY CA UroToday.com

Related by string. * berkeley . Berkeleys . Berkeley : UC Berkeley Graduate . UC Berkeley professor emeritus . UC Berkeley Haas . Berkeley DB / Ca . CAS . CAD . ca : SAN JOSE CA Marketwire . LOS ANGELES CA Marketwire . Los Angeles CA PRWEB . LOS ANGELES CA MARKET / : ORLANDO FL UroToday.com . UroToday.com Contributing Editor . USA UroToday.com . UroToday.com Contributing Medical * *

Related by context. All words. (Click for frequent words.) 73 leiomyomas 72 Surgical Treatment 70 Radiofrequency Ablation 70 UroToday.com 69 endoscopic ultrasonography 68 Carotid Stenting 68 Clinical Outcome 68 Neoplasms 67 Malignancy 67 Localized Prostate Cancer 67 Overactive Bladder 67 Clinical Relevance 66 Chronic Heart Failure 66 Systematic Review 66 Renal Artery 66 Hepatocellular Carcinoma 66 Venous Thromboembolism 66 Endometrial 66 CT Angiography 66 Male Infertility 66 Dual Antiplatelet Therapy 66 Adenomas 66 Benign Prostatic Hyperplasia BPH 66 Prospective Randomized 65 Prognostic Factors 65 Meta Analysis 65 Randomized Study 65 Gastric Cancer 65 Papillary 65 #F FDG PET 65 Endometrial Cancer 65 Adjuvant Chemotherapy 65 Intracerebral Hemorrhage 65 Aneurysm Repair 65 Metastases 64 urothelial carcinoma 64 Ischemic 64 osteoid osteoma 64 Randomized Controlled Trials 64 Duodenal 64 thrombus aspiration 64 Erythropoietic 64 Vasculature 64 Coronary Artery Bypass Graft 64 Myocardial Ischemia 64 Urinary Incontinence 64 Allogeneic 64 Catheter Ablation 64 Glioma 64 urothelial cancer 64 Cardiovascular Events 64 prostate cancer CaP 64 Treating Chronic 64 Controlled Trial 64 Nonalcoholic Fatty Liver Disease 64 Ultrasonography 64 Estrogen Receptor 64 Sipuleucel T 64 Acute Myocardial Infarction 64 Malignancies 64 Benign Prostatic Hyperplasia 64 Uterine 64 Patients Undergoing 64 Calcification 64 Chronic Pelvic Pain 64 Radical Prostatectomy 64 Infarction 64 Skeletal Muscle 64 Fracture Risk 64 Kidney Transplantation 64 myomas 64 Autoantibodies 63 Epithelium 63 Prostatitis 63 Vertebroplasty 63 thromboembolic disease 63 Esophageal 63 Prospective Randomized Trial 63 paraneoplastic 63 Stress Urinary Incontinence 63 Genetic Basis 63 Periodontal Disease 63 urolithiasis 63 Small Intestine 63 Disease Progression 63 Tonsillectomy 63 Hysterectomy 63 Chemoradiation 63 #:#-# [033] 63 Conjugated 63 Hyperlipidemia 63 Hypercholesterolemia 63 Arrhythmias 63 Uterine Cancer 63 Stenosis 63 Total Hip Replacement 63 Intracerebral 63 Pharmacodynamics 63 Patency 63 Hormone Therapy 63 Acute Ischemic Stroke 63 Invasive Breast Cancer 63 Knee Osteoarthritis 63 clinicopathologic 63 Postmenopausal Women 63 Observational Study 63 Carcinoma 63 Soft Tissue Sarcoma 63 See CLINICAL PHARMACOLOGY 63 Brain Metastases 63 Stenting Trial CREST 63 Growth Hormone Deficiency 63 Patellofemoral 63 Multicenter Study 63 Bladder Cancer 63 Motility 63 Resection 63 Infarct 63 Anthracycline 63 Non Alcoholic Fatty 63 Endothelium 63 valvular heart 63 Capsular 63 FDG-PET/CT 63 Histopathological 63 Cystectomy 63 Adenoma 63 transurethral resection 62 Coronary Angiography 62 Malformations 62 NAVISTAR R 62 Bare Metal Stent 62 bone scintigraphy 62 Malignant Melanoma 62 Genetic Markers 62 preoperative diagnosis 62 Robotic Assisted 62 Hematopoietic 62 Prolonged Survival 62 Molecular Basis 62 Peripheral Arterial 62 Immunosuppression 62 LVNC 62 osteoporotic vertebral fractures 62 paraganglioma 62 Uterine Fibroid Embolization 62 Carcinomas 62 Periodontitis 62 Cardiovascular Interventions 62 Catheterization 62 Phenotype 62 Randomized Controlled Trial 62 Ablation 62 Thromboembolism 62 Diastolic Heart Failure 62 Radioimmunotherapy 62 Hemodialysis Patients 62 Histologic 62 Thrombus 62 Non Alcoholic Steatohepatitis 62 MR Angiography 62 Cerebral Cortex 62 Cancer Recurrence 62 nephron sparing surgery 62 renal tumors 62 chronic prostatitis 62 Neurotoxicity 62 Angina pectoris 62 Polymorphism 62 Hematological 62 Thromboembolic 62 Unfractionated Heparin 62 Esophageal Cancer 62 Myocardial Infarction MI 62 Secondary Hyperparathyroidism 62 Cardiotoxicity 62 percutaneous vertebroplasty 62 #:#-# [031] 62 Sonography 62 sonographic appearance 62 Dysplasia 62 Microalbuminuria 62 Chronic Sinusitis 62 Pelvic Organ Prolapse 62 Histological 62 Severe Asthma 62 AA Amyloidosis 62 Lymphocytic 62 #:#-# [037] 62 Embolization 62 Thrombotic 62 Fibrosis 62 Hypertrophic 62 Hyperparathyroidism 62 Randomized Clinical Trial 62 pT2 62 Cardiovascular Outcomes 61 Metastatic Prostate Cancer 61 Rheumatoid Arthritis Patients 61 Cervical Spine 61 Idiopathic 61 metaplasia 61 Aortic Valve 61 Ranolazine 61 Intracranial Aneurysms 61 Atypical Hemolytic Uremic Syndrome 61 angiographically 61 Endothelial 61 Coronary artery bypass grafting 61 benign prostatic hypertrophy BPH 61 Liver Failure 61 Hormone Replacement 61 Nymox NX 61 Breast Carcinoma 61 Etiology 61 Placebo Controlled Trial 61 transurethral 61 Androgen 61 Replacement Therapy 61 Myelodysplastic Syndromes 61 Renal Cell Carcinoma 61 Allergic Rhinitis 61 Minimally Invasive Treatment 61 Diabetic Nephropathy 61 Stent Thrombosis 61 Prophylactic Treatment 61 Chronic Prostatitis 61 Polymorphisms 61 atherothrombotic disease 61 #:#-# [035] 61 Autologous 61 Adjuvant Therapy 61 Antiviral Therapy 61 Restenosis 61 Hypoparathyroidism 61 Squamous Cell Carcinoma 61 Prenatal Diagnosis 61 Colorectal Cancers 61 femoral neck fractures 61 Cognitive Impairment 61 Genetic Variation 61 Prognostic Value 61 Transcatheter 61 Prostatic 61 Acute Myocardial 61 Gastrointestinal Tract 61 Improve Survival 61 Autoimmune Disease 61 extramedullary 61 Breast Cancers 61 Breast Cancer Recurrence 61 Bivalirudin 61 ExTRACT TIMI 61 abdominal adiposity 61 Prostatectomy 61 paragangliomas 61 Coronary Revascularization 61 Cutaneous 61 Atrophic 61 J Clin 61 Drug Eluting 61 Neoadjuvant Chemotherapy 61 Carotid 61 percutaneous biopsy 61 Dermatol 61 Neoplasia 61 Increased Mortality 61 hamartomas 61 Bone Mineral Density 61 ADPKD 61 Angiographic 61 transabdominal 61 adrenalectomy 61 Low Dose 61 Chronic Rhinosinusitis 61 Advanced Renal Cell 61 Ischemic Stroke 61 Transurethral 61 Aortic Valve Replacement 61 Coronary Artery 61 Vitrectomy 61 B Cell Lymphoma 61 JAK Inhibitor 61 Kinase Inhibitors 61 Peptic Ulcer 61 Iron Overload 61 #F FDG PET CT 61 #-# Full Text 61 Total Knee Replacement 61 Multicenter 61 Prostate Cancers 61 Chronic Lyme Disease 61 Testis 61 Unresectable 61 invasive candidiasis 61 Interstitial cystitis 61 Urethral 61 Colorectal Cancer Patients 61 Subtypes 61 Valvular 61 Tyrosine Kinase Inhibitor 61 Coronary Arteries 61 Carotid Revascularization Endarterectomy vs. 61 F FDG PET 61 treat benign prostatic 61 Stent Restenosis 61 Parenteral Nutrition 61 Efficacious 61 Arch Neurol 61 Cardiac Allograft Rejection 61 J Am Coll 61 NMIBC 61 complement inhibitor eculizumab 61 endoscopic retrograde 61 Progenitor Cells 61 Liver Transplantation 61 Hemolysis 61 Bone Metastases 61 Intervention Trial GAIT 61 Aortic Stenosis 61 Oxidative Stress 61 Cytogenetic 61 Ectopic 61 Renal Anemia 61 clinicopathological 61 uricase 60 NICE SUGAR 60 Pancreatic 60 immunohistochemical 60 Neuroendocrine Tumors 60 Autologous Stem Cell Transplantation 60 Epidermal Growth Factor Receptor 60 Intervention Trial 60 retroperitoneal 60 reflux esophagitis 60 varicoceles 60 Prehypertension 60 Intravascular 60 Radiation Dose 60 Skin Lesions 60 primary hyperparathyroidism 60 Environ Health Perspect 60 Electroencephalography 60 Soft Tissue 60 Suicidality 60 Chronic lymphocytic leukemia 60 Colorectal Adenomas 60 intracerebral 60 EBUS FNA 60 pelvic lymphadenectomy 60 Surgical Procedures 60 Multicenter Trial 60 etiologic 60 C Reactive Protein 60 Rectal Cancer 60 Immune Mediated 60 Sentinel Lymph Node Biopsy 60 osteochondroma 60 Hepatotoxicity 60 BJU International 60 endometrial hyperplasia 60 Cannabinoid 60 Invasive Fungal Infections 60 thyroid nodules 60 Neuroprotective Effects 60 Osteomyelitis 60 Oral Mucositis 60 adenomatous 60 Inflammatory Bowel Diseases 60 Cognitive Function 60 Esophagitis 60 Sexual Function 60 Tiotropium 60 risk reducing salpingo 60 transplantation HSCT 60 Atopic Dermatitis 60 Heart Failure Patients 60 Recurrent Breast Cancer 60 Obese Patients 60 Evaluation WISE 60 incidentalomas 60 Imaging Diagnostic 60 Endocarditis 60 venous thromboembolic disease 60 Apolipoprotein E 60 multicentric 60 Atrial 60 Fat Grafting 60 Diagnostic Criteria 60 Comorbidities 60 Signaling Pathway 60 Lumbar Spine 60 surgically resected 60 Therapeutic Potential 60 Ultrasound Guided 60 bronchogenic carcinoma 60 Differential Diagnosis 60 liver resection 60 Pituitary 60 PEMF therapy 60 Prolongs Survival 60 Minimally Invasive Procedure 60 subtrochanteric 60 Spinal Manipulation 60 Drug Prevents 60 Carotid Endarterectomy 60 Nilotinib 60 #:#-# [029] 60 Embolic Protection Device 60 TLIF 60 NIDDM 60 Multiethnic Study 60 Chlamydia trachomatis 60 Onychomycosis 60 Pooled Analysis 60 Percutaneous Tibial Nerve Stimulation 60 Optical Coherence Tomography 60 Fluorouracil 60 Lesion 60 Total Knee Arthroplasty 60 Venous thromboembolism 60 β blockers 60 Occlusive Disease 60 Leukemias 60 mucinous 60 Asymptomatic 60 transient elastography 60 carcinoid tumor 60 Nonsurgical 60 extra articular 60 prospective multicenter study 60 Coronary Artery Bypass Surgery 60 Nodule 60 Androgen Deprivation Therapy 60 Clinical Trial Results 60 idiopathic myelofibrosis 60 Sentinel node biopsy 60 Neuroprotection 60 hepatic cirrhosis 60 prostate TURP 60 metastatic neuroendocrine tumors 60 Prognostic Significance 60 Oral Cavity 60 Cardiol 60 Urinary Catheter 60 Intracranial 60 calcaneal fractures 60 Ischaemic 60 Randomized Evaluation 60 Statin Therapy 60 Venous Thrombosis 60 Androgen Receptor 60 cytoreductive surgery 60 granulomatous 60 Well Tolerated 60 HER2 Positive Breast Cancer 60 Mouse Model 60 Cilostazol 60 Alkaline Phosphatase 60 Smooth Muscle 60 Kidney Transplant Patients 60 J. Clin 60 transvaginal sonography 60 prognostic significance 60 Hypotension 60 HeFH 60 pulmonary metastases 60 Placebo Controlled Study 59 Contraindications 59 #:#-# [023] 59 EUS FNA 59 Basal Cell Carcinoma 59 Vertebral Compression Fractures 59 Telomere 59 Benign prostatic hyperplasia BPH 59 Mitral Regurgitation 59 occlusive disease 59 gallstone disease 59 gastric cardia 59 Aggressive Reduction 59 Inactivation 59 Beta Blocker 59 Diabetic Neuropathy 59 BMC Musculoskeletal Disorders 59 multimodality therapy 59 infective endocarditis 59 Prospective Multicenter 59 Hematopoietic Stem Cells 59 Virtual Colonoscopy 59 Stress Incontinence 59 AJNR 59 Keratitis 59 aortic root replacement 59 Basal Cell 59 spontaneous regression 59 Myelofibrosis 59 Elderly Patients 59 Genetic Marker 59 Valve Replacement 59 Extracellular Matrix 59 Thiazolidinediones 59 Brain Stimulation 59 Abnormality 59 Gene Mutation 59 Degarelix 59 clinico pathological 59 Microvascular 59 Complication Rates 59 Vertebral 59 Artificial Organs 59 Congenital Heart Disease 59 Hormone Receptor Positive 59 Ovarian Cancers 59 Non Invasive 59 Inguinal 59 thymectomy 59 Renal Cancer 59 Adiposity 59 Antitumor Activity 59 thyroid dysfunction 59 Lowers Risk 59 Cancer Incidence Mortality 59 Carcinoid 59 Lymphatic 59 Dilated Cardiomyopathy 59 Biological Effects 59 TRUS 59 Breast Tumors 59 malignant lymphomas 59 renal biopsy 59 Slows Progression 59 Mucositis 59 Gastrointestinal Stromal Tumors 59 Hepatocellular Carcinoma HCC 59 Appropriateness Criteria 59 Adenocarcinoma 59 Chronic Constipation 59 Autoimmune Diseases 59 Transplant Rejection 59 Blocked Arteries 59 Uterine Fibroids 59 urinary incontinence UI 59 REACH Registry 59 Laparoscopy 59 Ventricular 59 Subclinical 59 Prospective Randomized Study 59 Photodynamic Therapy 59 Prolapse 59 Ischemia 59 carotid stenosis 59 multicenter trials 59 Candidiasis 59 Adverse Event 59 Aggressive Prostate Cancer 59 Stenting 59 Vulvar 59 Preoperative 59 Adjunctive 59 hypovitaminosis D 59 Hernia Repair 59 Follicular Lymphoma 59 Pemphigus 59 transesophageal echocardiography 59 Eluting Stent 59 Cytotoxicity 59 Subgroup Analysis 59 Bacteremia 59 Generalized Anxiety Disorder 59 ASCUS 59 Ureteral 59 Left Ventricular 59 venous malformations 59 Pemphigus Vulgaris 59 IPAH 59 mediastinitis 59 monogenic 59 EURIDIS 59 haematuria 59 Robot Assisted 59 Chronic HCV 59 Vertebral Fractures 59 Excretion 59 differential gene expression 59 Treatment Regimens 59 Patients Treated With 59 liver metastasis 59 Hypothyroidism 59 histopathologic 59 antiphospholipid antibodies 59 metastatic malignant 59 Septic Shock 59 Andropause 59 Hyperplasia 59 Depressive Symptoms 59 Thermal Ablation 59 Metastatic Melanoma 59 Contrast Enhanced 59 Alveolar 59 Systolic Hypertension 59 Anticancer Drugs 59 immunohistochemical analysis 59 Non Invasive Treatment 59 papillary thyroid carcinoma 59 Combination Treatment 59 Lipoprotein 59 neoadjuvant 59 Sonographic 59 Immunohistochemistry 59 Improved Survival 59 Nocturia 59 Partial Nephrectomy 59 perioperative morbidity 59 Ventricular Tachycardia 59 Renal Function 59 Laryngeal Cancer 59 Predict Risk 59 Clinical Evaluation 59 Clostridium difficile Infection 59 Randomized Trials 59 #p# [003] 59 Tumor Response 59 Orthostatic Hypotension 59 Unstable Angina 59 ST Segment Elevation 59 Female Stress Urinary 59 Lipid Lowering Treatment 59 Mutational 59 Catheter Associated 59 Estrogen Therapy 59 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 59 polyarticular 59 postoperative atrial fibrillation 59 Reperfusion Injury 59 Rhinosinusitis 59 Phase III Clinical Trial 59 Prostate Cancer Treatment 59 Survival Benefit 59 arthrosis 59 Adrenal Fatigue 59 Preclinical Study 59 Bucindolol 59 Controlled Study 59 Aortic 59 chronic thromboembolic pulmonary 59 histological subtype 59 Inflammatory Markers 59 myocardial revascularization 59 paclitaxel eluting stents 59 Hallux 59 Tumor Progression 59 Lenalidomide 59 J Nutr 59 Pathologic 59 Zoledronic Acid 59 Accelerated Partial Breast Irradiation 59 Cancer Res 59 Randomized Comparison 59 artery embolization 59 prospective nonrandomized 59 Lung Injury 59 Proves Effective 59 Lupus Nephritis 59 Oligonucleotides 59 Colorectal 59 Antiplatelet Therapy 59 FDG PET imaging 59 Breast Cancer Risk 59 Psychological Stress 59 transcranial Doppler ultrasound 59 atrophic gastritis 59 #:#-# [001] 59 Myelodysplastic Syndrome 59 colorectal adenoma 59 endoluminal stent graft 58 Fecal Incontinence 58 Albuminuria 58 Brain Wiring 58 Lymphoid 58 Legg Calvé Perthes disease 58 Coronary Disease 58 fibroma 58 Fibroblast 58 #:#-# [028] 58 EuroIntervention 58 Von Willebrand Disease 58 androgen deficiency 58 Laryngoscope 58 Hepatic 58 Advanced Melanoma 58 candidemia 58 Breast Cancer Treatment 58 Improves Outcomes 58 calculi 58 Systemic lupus erythematosus 58 Prostate Cancer Recurrence 58 Acute Coronary Syndromes 58 hemodilution 58 Insulin Therapy 58 lichen planus 58 Brain Tumors 58 Postmenopausal Hormone Therapy 58 Spinal Fluid 58 Natalizumab 58 Irritable Bowel 58 Severe Sepsis 58 Free Full Text 58 myopathies 58 Interferon Beta 58 Hypothalamic 58 Osteoporotic 58 Lysis 58 Lung Cancers 58 Reproducibility 58 Phase III Clinical Trials 58 Emboli 58 Immunotherapeutic 58 Brain Aneurysms 58 valve implantation 58 Meningiomas 58 Allografts 58 Node Positive 58 Nephrectomy 58 hypervascular tumors 58 ventricular myocardium 58 Tumor Growth 58 Reflux Disease 58 Main Outcome Measure 58 Bacterial Vaginosis 58 prostate cancer PCa 58 Beneficial Effects 58 Inflammatory Arthritis 58 Retinoic Acid 58 Afib 58 KRAS oncogene 58 paroxysmal nocturnal hemoglobinuria 58 pelvic lymph node dissection 58 Renal Disease 58 Pharmacologic 58 ADAGIO study 58 supratentorial 58 Cognitive Decline 58 J Clin Endocrinol Metab 58 Cardiovasc 58 predisposing factor 58 Bronchiectasis 58 Carcinogenesis 58 Metastatic Colorectal Cancer 58 Elevated Levels 58 Endothelial Function 58 Appears Safe 58 ANCA associated 58 Anticoagulation 58 Y Gastric Bypass 58 Contraceptive Use 58 Panic Disorder 58 Intracoronary 58 Ultrasonographic 58 Prostate Px + 58 urography 58 ischemic mitral regurgitation 58 Virtual Histology 58 Prospective Cohort Study 58 CP CPPS 58 gastrectomy 58 Practice Patterns 58 Systemic Sclerosis 58 thromboembolic 58 Polycystic Ovary Syndrome 58 Prostate Biopsy 58 Hurthle cell 58 parathyroidectomy 58 Male Pattern Baldness 58 Pulmonary Embolism 58 PICSO ® 58 Levels Linked 58 Pulmonary Vein Isolation 58 perioperative complications 58 endobronchial 58 Myocardial Infarction Study 58 Salivary 58 Implantation 58 Recurrences 58 Am J Clin 58 Val HeFT 58 Placebo Effect 58 J Pediatr 58 sonographic diagnosis 58 Heritability 58 Spine Patient Outcomes 58 Chemotherapeutic Agents 58 mycosis fungoides 58 Arterial Disease 58 Effective Treatments 58 Fatty Liver Disease 58 Metabolic Endocrinology 58 Dehydrogenase 58 Langerhans cell histiocytosis 58 Cataract Surgery 58 Digital Mammographic Imaging 58 Clinical Trials Review 58 Helicobacter pylori infection 58 Immunologic 58 Iron Deficiency 58 Genital Herpes 58 Neurotology 58 Maturitas 58 hematuria 58 NOTES Natural Orifice 58 Axillary 58 gene polymorphism 58 Phenotypes 58 #:#-# [024] 58 Parathyroid 58 gastric adenocarcinoma 58 urethral strictures 58 J Am Acad 58 Improves Survival 58 Gynecomastia 58 colorectal liver metastases 58 Hypertriglyceridemia 58 Anticoagulants 58 Long Term Outcomes 58 Dysmenorrhea 58 Acute Renal Failure 58 Dendritic Cells 58 Dose Response 58 interstitial brachytherapy 58 CLINICAL PHARMACOLOGY 58 Demonstrates Efficacy 58 Therapeutic Advances 58 Breast Density 58 KRAS mutation 58 Proteinuria 58 Synovial 58 Patient Populations 58 Gene Linked 58 Predisposition 58 Female Sexual Arousal 58 Insulin Sensitivity 58 Antitumor 58 Risk Stratification 58 nonrandomized studies 58 abacavir Ziagen 58 Progressive Multifocal Leukoencephalopathy 58 Electrical Stimulation 58 Diabetic nephropathy 58 Kidney Stones 58 II Clinical Trial 58 Gastric Bypass Surgery 58 USA UroToday.com 58 Arch Surg 58 cystic lesions 58 prostate carcinoma 58 adenomatous polyps 58 Myocardial 58 Fulvestrant 58 Febrile Neutropenia 58 Cardiac Rhythm 58 STRIDE PD 58 autonomic dysfunction 58 thromboembolism 58 PREVENT IV 58 acetabular fractures 58 Peripheral Blood 58 giant cell arteritis 58 genes differentially expressed 58 Barrett Esophagus 58 Lower Extremity 58 longitudinal cohort study 58 Radiofrequency Ablation RFA 58 endometrial carcinoma 58 Stomach Cancer 58 metachronous 58 Arch Dis Child 58 esophagogastric 58 adenoidectomy 58 artery stenosis 58 Clinical Trial Data 58 Fatty Liver 58 transarterial 58 Pulmonary Artery 58 conventional angiography 58 thrombophilia 58 Clinical Efficacy 58 murine model 58 allogeneic hematopoietic cell 58 Recurrent Stroke 58 Diabetic Patients 58 Non Melanoma Skin 58 Complicated Skin 58 Cyclooxygenase 2 58 REMINDER ORLive Presents 58 Myocardial Infarction 58 Advanced Prostate Cancer 58 Nanobacteria 58 Spinal Fractures 58 adjuvant radiotherapy 58 Am J Cardiol 58 sonographic findings 58 Echocardiographic 58 Patients Treated 58 Autoimmunity 58 Randomised Controlled Trial 58 aortic insufficiency 58 Postmenopausal 58 IDDM 58 Autoimmune Disorders 58 hamartoma 58 Blood Pressure Lowering 58 Premenopausal Women 58 Novel Antibiotic 58 Nat Genet 58 Slow Progression 58 Onc 58 computed tomographic 58 Cardiogenic Shock 58 Digestive Tract 58 aetiological 58 malignant neoplasms 58 Chronic Myelogenous Leukemia 58 external beam radiotherapy 58 Biliary 58 radioiodine therapy 58 Genes Identified 58 vertebral compression fractures 58 Pharmacokinetic Study 58 Cancer Epidemiol Biomarkers Prev 58 Laser Lipolysis 58 aminotransferase 58 collagenous colitis 58 Contrast Agent 58 Enzyme Replacement Therapy 58 Antigen Specific 58 ASBMR 58 Patient Registry 58 Transdermal Delivery 58 Bronchiolitis 58 Glucosamine Chondroitin Arthritis 58 Neural Stem Cells 58 OPCAB 58 NewsRx.com 58 Peritoneal 58 Dyslipidemia 58 Critical Limb Ischemia CLI 58 CHARISMA trial 58 Ankylosing spondylitis 58 Fondaparinux 58 Chronic Myeloid Leukemia 58 cytologic 58 Menopausal Symptoms 58 Misdiagnosis 58 Distal 58 gadolinium enhanced 58 Computed Tomographic 58 nonmetastatic 58 Cardiovascular Disease Risk 58 Cardiomyocytes 57 Preterm Delivery 57 carotid angioplasty 57 Contralateral 57 HGPIN 57 Targeted Therapy 57 aetiology 57 observational cohort study 57 Testicular Cancer 57 Long Term Efficacy 57 Abdominal Fat 57 Oncogene 57 arterial calcification 57 lymphadenectomy 57 Endothelial dysfunction 57 Image Guided 57 Neurodegenerative 57 Implantable Cardioverter Defibrillator 57 Adult Stem Cell Therapy 57 Phase 2b Study 57 Fibrinogen 57 J Urol 57 bicuspid aortic valves 57 Pediatric Patients 57 Correlates 57 Spasticity 57 Oral Fingolimod 57 Deep Venous Thrombosis 57 obliterans 57 prostatitis 57 Molecular Mechanisms 57 Breast Tissue 57 Musculo Skeletal Disorders 57 Attenuates 57 Therapeutic Effects 57 Histopathologic 57 prospective multicentre 57 gene polymorphisms 57 Cerebellar 57 Peripheral Artery Disease 57 retrospective cohort study 57 T1DM

Back to home page